G282-2923 Screening compound: N-cyclopentyl-7-ethyl-6-methyl-1-(morpholine-4-carbonyl)-8-oxo-5H,6H,7H,8H-imidazo[1,5-a]pyrazine-6-carboxamide

G282-2923 Screening compound: N-cyclopentyl-7-ethyl-6-methyl-1-(morpholine-4-carbonyl)-8-oxo-5H,6H,7H,8H-imidazo[1,5-a]pyrazine-6-carboxamide
G282-2923 Screening compound: N-cyclopentyl-7-ethyl-6-methyl-1-(morpholine-4-carbonyl)-8-oxo-5H,6H,7H,8H-imidazo[1,5-a]pyrazine-6-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G282-2923
N-cyclopentyl-7-ethyl-6-methyl-1-(morpholine-4-carbonyl)-8-oxo-5H,6H,7H,8H-imidazo[1,5-a]pyrazine-6-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G282-2923

Molecular Formula

C20H29N5O4 (C20 H29 N5 O4)

Compound Name

N-cyclopentyl-7-ethyl-6-methyl-1-(morpholine-4-carbonyl)-8-oxo-5H,6H,7H,8H-imidazo[1,5-a]pyrazine-6-carboxamide

IUPAC name

N-cyclopentyl-7-ethyl-6-methyl-1-(morpholine-4-carbonyl)-8-oxo-5H6H7H8H-imidazo[15-a]pyrazine-6-carboxamide

SMILES

CCN(C(C)(Cn1c2c(C(N3CCOCC3)=O)nc1)C(NC1CCCC1)=O)C2=O

InChI

InChI=1S/C20H29N5O4/c1-3-25-18(27)16-15(17(26)23-8-10-29-11-9-23)21-13-24(16)12-20(25,2)19(28)22-14-6-4-5-7-14/h13-14H,3-12H2,1-2H3,(H,22,28)/t20-/m0/s1

InChI Key

OCJPHITUXYIFDN-FQEVSTJZSA-N

MDL Number (MFCD)

MFCD27212908

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

403.48

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

0.257

Distribution Coefficient, logD

0.257

Water Solubility, LogSw

-1.44

Polar Surface Area

76.329

Acid Dissociation Constant (pKa)

15.47

Base Dissociation Constant (pKb)

1.60

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

70.00

G282-2923 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Anticancer Library (62698 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Cyclic Ugi PPI Library (9586 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

Targeted Diversity Library (40567 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with G282-2923 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G282-2923?
Check Price and Availability of G282-2923, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G282-2923 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G282-2923
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G282-2923
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G282-2923 available by request